Eli Lilly Corp. buy Royal Bank of Canada
Start price
08.07.26
/
50%
€1,072.0
Target price
08.07.27
€1,313.9
Performance (%)
-4.37%
Price
07.08.26
€1,025.2
Summary
This prediction is currently active. With a performance of -4.37%, the BUY prediction for Eli Lilly Corp. by Royal_Bank_of_Canada is down slightly. This prediction currently runs until 08.07.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Eli Lilly Corp. | 2.932% |
| iShares Core DAX® | 2.573% |
| iShares Nasdaq 100 | 4.858% |
| iShares Nikkei 225® | 5.590% |
| iShares S&P 500 | 3.250% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (LLY) had its price target raised by Royal Bank Of Canada from $1,250.00 to $1,500.00. They now have an "outperform" rating on the stock.
Ratings data for LLY provided by MarketBeat